Trends in Biotechnology

TRENDS IN BIOTECHNOLOGY (TRENDS BIOTECHNOL, ISSN 0167-7799) is a premier monthly review journal published by Cell Press, an imprint of Elsevier. Renowned for its authoritative and forward-looking content, the journal serves as a critical resource for researchers, policymakers, and industry professionals seeking to stay abreast of the most significant advances and emerging trends across the broad spectrum of biotechnology. Its scope encompasses fundamental and applied aspects of the field, including but not limited to genetic engineering, synthetic biology, metabolic engineering, bioprocess engineering, agricultural biotechnology, environmental remediation, and biomedical applications such as gene therapy and drug delivery. The journal exclusively publishes commissioned, high-impact review articles, perspectives, and forum pieces that synthesize current knowledge, identify key challenges, and forecast future directions. This curated format ensures that each contribution offers deep, critical analysis rather than incremental research findings. A distinguishing feature of TRENDS IN BIOTECHNOLOGY is its strong translational focus, bridging the gap between laboratory discoveries and commercial or clinical implementation. With an exceptional Impact Factor of 16.600 for 2026, the journal is firmly positioned in the JCR Q1 quartile, ranking among the most influential and highly cited titles in the biotechnology category. While it is not an open access journal by default, authors have the option to publish open access via a Creative Commons license for an article processing charge. Through its rigorous editorial standards and visionary content, TRENDS IN BIOTECHNOLOGY remains an indispensable guide for anyone invested in the future of biotechnology.